These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 19506320)
1. GSK-3beta, a therapeutic target for cardiomyocyte protection. Miura T; Miki T Circ J; 2009 Jul; 73(7):1184-92. PubMed ID: 19506320 [TBL] [Abstract][Full Text] [Related]
2. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury. Miura T; Nishihara M; Miki T J Pharmacol Sci; 2009 Feb; 109(2):162-7. PubMed ID: 19179805 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Miura T; Tanno M Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653 [TBL] [Abstract][Full Text] [Related]
5. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. Park SS; Zhao H; Jang Y; Mueller RA; Xu Z J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Yao LL; Huang XW; Wang YG; Cao YX; Zhang CC; Zhu YC Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1310-9. PubMed ID: 20154265 [TBL] [Abstract][Full Text] [Related]
7. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta. Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440 [TBL] [Abstract][Full Text] [Related]
8. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050 [TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017 [TBL] [Abstract][Full Text] [Related]
11. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. Mozaffari MS; Schaffer SW Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149 [TBL] [Abstract][Full Text] [Related]
12. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion. Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore. Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218 [TBL] [Abstract][Full Text] [Related]
14. Plant Natural Product Formononetin Protects Rat Cardiomyocyte H9c2 Cells against Oxygen Glucose Deprivation and Reoxygenation via Inhibiting ROS Formation and Promoting GSK-3β Phosphorylation. Cheng Y; Xia Z; Han Y; Rong J Oxid Med Cell Longev; 2016; 2016():2060874. PubMed ID: 27034732 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587 [TBL] [Abstract][Full Text] [Related]
16. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening. Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphodiesterases leads to prevention of the mitochondrial permeability transition pore opening and reperfusion injury in cardiac H9c2 cells. Chanoit G; Zhou J; Lee S; McIntosh R; Shen X; Zvara DA; Xu Z Cardiovasc Drugs Ther; 2011 Aug; 25(4):299-306. PubMed ID: 21643720 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation. Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H922-30. PubMed ID: 21217064 [TBL] [Abstract][Full Text] [Related]